Phase 1/2 study of carfilzomib, pomalidomide, and dexamethasone (KPd) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM): A Multiple Myeloma Research Consortium multicenter study
Rosenbaum, Cara Ann, Stephens, Leonor Ano, Kukreti, Vishal, Zonder, Jeffrey A., Cole, Craig, Zimmerman, Todd M., Reece, Donna Ellen, Berdeja, Jesus G., Severson, Erica, Revethis, Andrea, Wolfe, Brittany, McDonnell, Kathryn, Nam, Jennifer, Griffith, Kent A., Jakubowiak, Andrzej J.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article